{"SPADE_UN_15507": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15507", "Peptide Name": "BP100 [Y10I]", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "KKLFKKILKIL", "Sequence Length": 11, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:MCF-7/ADM (IC50=21.3±2.1µM); MCF-7 (IC50=21.5±1.9µM); K562 (IC50=23.7±2.3µM); K562/ADM (IC50=24.6±1.6µM)", "Hemolytic Activity": "Rabbit erythrocytes:7.5% Hemolysis=160µM", "Cytotoxicity": "GES-1:IC50=76.9±6.7µM", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C69H126N16O12", "Mass": 1371.84, "PI": 10.6, "Net Charge": 5, "Hydrophobicity": 0.34, "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "Design, synthesis and biological evaluation of novel peptides as potential agents with anti-tumor and multidrug resistance-reversing activities", "Pubmed ID": "28474125", "Reference": "Amino Acids. 2017 Aug;49(8)1355-1364", "Author": "Zhang B, Shi W, Li J, Liao C, Li M, Huang W, Qian H.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=28474125"}], "Frequent Amino Acids": "KLI", "Absent Amino Acids": "ACDEGHMNOPQRSTUVWY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 6, "Polar Residues": 5, "Positive Residues": 5, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_02049", "Similarity": 1.0, "Sequence": "FIGGIISLIKKLF"}, {"SPADE_ID": "SPADE_N_02050", "Similarity": 1.0, "Sequence": "FIGGIISFIKKLF"}, {"SPADE_ID": "SPADE_N_06699", "Similarity": 1.0, "Sequence": "FALALKAKKL"}]}}}